Lower all-cause mortality rates in patients harboring pituitary carcinoma following the introduction of temozolomide

Genya Aharon-Hananel, Ruth Percik, Muhamad Badarna, Inbal Uri, Amit Tirosh*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Lower all-cause mortality rates in patients harboring pituitary carcinoma following the introduction of temozolomide'. Together they form a unique fingerprint.

Medicine & Life Sciences